Apimeds Pharmaceuticals US, Inc. (APUS)

APUS Statistics

Total Valuation

APUS has a market cap or net worth of $23.89 million. The enterprise value is $15.66 million.

Market Cap	23.89M
Enterprise Value	15.66M

Important Dates

The last earnings date was Tuesday, August 19, 2025, after market close.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

APUS has 12.58 million shares outstanding. The number of shares has increased by 28.67% in one year.

Current Share Class	12.58M
Shares Outstanding	12.58M
Shares Change (YoY)	+28.67%
Shares Change (QoQ)	+31.19%
Owned by Insiders (%)	18.06%
Owned by Institutions (%)	1.89%
Float	3.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.49
P/TBV Ratio	2.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.79, with a Debt / Equity ratio of 0.05.

Current Ratio	12.79
Quick Ratio	10.80
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.77

Financial Efficiency

Return on equity (ROE) is -82.20% and return on invested capital (ROIC) is -45.40%.

Return on Equity (ROE)	-82.20%
Return on Assets (ROA)	-42.42%
Return on Invested Capital (ROIC)	-45.40%
Return on Capital Employed (ROCE)	-37.01%
Revenue Per Employee	n/a
Profits Per Employee	-$1.85M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.87
200-Day Moving Average	n/a
Relative Strength Index (RSI)	49.73
Average Volume (20 Days)	113,515

Short Selling Information

The latest short interest is 3,216, so 0.03% of the outstanding shares have been sold short.

Short Interest	3,216
Short Previous Month	10,359
Short % of Shares Out	0.03%
Short % of Float	0.11%
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.60M
Pretax Income	-3.71M
Net Income	-3.71M
EBITDA	n/a
EBIT	-3.60M
Earnings Per Share (EPS)	-$0.43

Balance Sheet

The company has $8.74 million in cash and $500,100 in debt, giving a net cash position of $8.24 million or $0.65 per share.

Cash & Cash Equivalents	8.74M
Total Debt	500,100
Net Cash	8.24M
Net Cash Per Share	$0.65
Equity (Book Value)	9.74M
Book Value Per Share	0.77
Working Capital	9.54M

Cash Flow

In the last 12 months, operating cash flow was -$3.67 million and capital expenditures -$13,369, giving a free cash flow of -$3.68 million.

Operating Cash Flow	-3.67M
Capital Expenditures	-13,369
Free Cash Flow	-3.68M
FCF Per Share	-$0.29

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APUS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.67%
Shareholder Yield	-28.67%
Earnings Yield	-15.52%
FCF Yield	-15.41%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2